Course Overview

This year’s conference will provide a robust and comprehensive scientific approach integrating cutting-edge knowledge on the subjects of lung cancer and head & neck cancer. We will review the most recent developments in this field from the data presented at American Society of Clinical Oncology (ASCO) 2025 annual meeting and European Society for Medical Oncology (ESMO) 2025 annual meeting. Each session will include expert lectures, panel discussion, and live Q&A.

Two tracks will be offered this year. The 2025 Lung Cancer track will focus on treatment options for small cell and non-small cell lung cancer. In the Head & Neck track, we will discuss new advances in the treatment of head and neck cancer. The symposium will center on a multidisciplinary approach and application of new clinical trial research data on clinical trials and new treatment options.

Target Audience

This symposium is designed for physicians, advanced practice providers, nurses, pharmacists, and other healthcare professionals specializing in lung cancer and head & neck cancers.

Click here to see pricing, program agenda and to register.